Robert Wild

Robert Wild is currently the Acting Chief Executive Officer at Azkarra Therapeutics. Prior to this role, Robert held positions such as Acting Chief Scientific Officer at Dracen Pharmaceuticals, President and Founder at RC Wild BioPharma Consulting, LLC, and Executive In Residence at Pandect Bioventures and ShangPharma Innovation. Robert has a strong background in oncology drug discovery and development, with experience at companies like Eli Lilly and Company, OSI Pharmaceuticals Inc., and Bristol-Myers Squibb. Robert holds a Ph.D. in Pharmacology from the University of Minnesota and a B.S. in Biochemistry from the same institution.